Medical Subject Headings
MeSH Tree Structures - 2011
C20 - Immune System Diseases
- Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]
- Addison Disease [C20.111.163]
- Anemia, Hemolytic, Autoimmune [C20.111.175]
- Anti-Glomerular Basement Membrane Disease [C20.111.190]
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis [C20.111.193]
- Antiphospholipid Syndrome [C20.111.197]
- Arthritis, Rheumatoid [C20.111.199]
- Autoimmune Diseases of the Nervous System [C20.111.258]
- Demyelinating Autoimmune Diseases, CNS [C20.111.258.250]
- Diffuse Cerebral Sclerosis of Schilder [C20.111.258.250.175]
- Encephalomyelitis, Acute Disseminated [C20.111.258.250.350]
- Leukoencephalitis, Acute Hemorrhagic [C20.111.258.250.425]
- Multiple Sclerosis [C20.111.258.250.500]
- Myelitis, Transverse [C20.111.258.250.550]
- Neuromyelitis Optica [C20.111.258.250.600]
- Lambert-Eaton Myasthenic Syndrome [C20.111.258.350]
- Leukoencephalitis, Acute Hemorrhagic [C20.111.258.450]
- Myasthenia Gravis [C20.111.258.500]
- Nervous System Autoimmune Disease, Experimental [C20.111.258.625]
- Polyradiculoneuropathy [C20.111.258.750]
- Stiff-Person Syndrome [C20.111.258.850]
- Uveomeningoencephalitic Syndrome [C20.111.258.925]
- Vasculitis, Central Nervous System [C20.111.258.962]
- Demyelinating Autoimmune Diseases, CNS [C20.111.258.250]
- Autoimmune Lymphoproliferative Syndrome [C20.111.288]
- Dermatitis Herpetiformis [C20.111.318]
- Diabetes Mellitus, Type 1 [C20.111.327]
- Glomerulonephritis, IGA [C20.111.525]
- Glomerulonephritis, Membranous [C20.111.535]
- Graves Disease [C20.111.555]
- Hepatitis, Autoimmune [C20.111.567]
- Lambert-Eaton Myasthenic Syndrome [C20.111.580]
- Lupus Erythematosus, Systemic [C20.111.590]
- Ophthalmia, Sympathetic [C20.111.709]
- Pemphigoid, Bullous [C20.111.730]
- Pemphigus [C20.111.736]
- Polyendocrinopathies, Autoimmune [C20.111.750]
- Purpura, Thrombocytopenic, Idiopathic [C20.111.759]
- Thyroiditis, Autoimmune [C20.111.809]
- Blood Group Incompatibility [C20.188]
- Glomerulonephritis, Membranoproliferative [C20.425]
- Graft vs Host Disease [C20.452]
- Hypersensitivity [C20.543]
- Drug Hypersensitivity [C20.543.206]
- Environmental Illness [C20.543.312]
- Hypersensitivity, Delayed [C20.543.418]
- Hypersensitivity, Immediate [C20.543.480]
- Anaphylaxis [C20.543.480.099]
- Asthma, Aspirin-Induced [C20.543.480.149]
- Conjunctivitis, Allergic [C20.543.480.200]
- Dermatitis, Atopic [C20.543.480.343]
- Eosinophilic Esophagitis [C20.543.480.356]
- Food Hypersensitivity [C20.543.480.370]
- Respiratory Hypersensitivity [C20.543.480.680]
- Urticaria [C20.543.480.904]
- Immune Complex Diseases [C20.543.520]
- Latex Hypersensitivity [C20.543.600]
- Wissler's Syndrome [C20.543.928]
- Immune Reconstitution Inflammatory Syndrome [C20.608]
- Immunologic Deficiency Syndromes [C20.673]
- Agammaglobulinemia [C20.673.088]
- Ataxia Telangiectasia [C20.673.290]
- Common Variable Immunodeficiency [C20.673.330]
- Dysgammaglobulinemia [C20.673.430]
- HIV Infections [C20.673.480]
- Acquired Immunodeficiency Syndrome [C20.673.480.040]
- AIDS Arteritis, Central Nervous System [C20.673.480.048]
- AIDS-Associated Nephropathy [C20.673.480.050]
- AIDS Dementia Complex [C20.673.480.070]
- AIDS-Related Complex [C20.673.480.080]
- AIDS-Related Opportunistic Infections [C20.673.480.100]
- HIV-Associated Lipodystrophy Syndrome [C20.673.480.400]
- HIV Enteropathy [C20.673.480.480]
- HIV Seropositivity [C20.673.480.500]
- HIV Wasting Syndrome [C20.673.480.520]
- Deltaretrovirus Infections [C20.673.483]
- Leukocyte-Adhesion Deficiency Syndrome [C20.673.600]
- Lymphopenia [C20.673.627]
- Phagocyte Bactericidal Dysfunction [C20.673.774]
- Severe Combined Immunodeficiency [C20.673.815]
- Wiskott-Aldrich Syndrome [C20.673.972]
- Immunoproliferative Disorders [C20.683]
- Hypergammaglobulinemia [C20.683.460]
- Lymphoproliferative Disorders [C20.683.515]
- Autoimmune Lymphoproliferative Syndrome [C20.683.515.124]
- Giant Lymph Node Hyperplasia [C20.683.515.250]
- Immunoblastic Lymphadenopathy [C20.683.515.501]
- Immunoproliferative Small Intestinal Disease [C20.683.515.512]
- Infectious Mononucleosis [C20.683.515.515]
- Leukemia, Hairy Cell [C20.683.515.517]
- Leukemia, Lymphoid [C20.683.515.528]
- Lymphangiomyoma [C20.683.515.710]
- Lymphoma [C20.683.515.761]
- Composite Lymphoma [C20.683.515.761.150]
- Hodgkin Disease [C20.683.515.761.355]
- Lymphoma, Non-Hodgkin [C20.683.515.761.480]
- Burkitt Lymphoma [C20.683.515.761.480.100]
- Lymphoma, B-Cell [C20.683.515.761.480.150]
- Burkitt Lymphoma [C20.683.515.761.480.150.165]
- Lymphoma, AIDS-Related [C20.683.515.761.480.150.450]
- Lymphoma, B-Cell, Marginal Zone [C20.683.515.761.480.150.570]
- Lymphoma, Large B-Cell, Diffuse [C20.683.515.761.480.150.585]
- Lymphoma, Primary Effusion [C20.683.515.761.480.150.592]
- Lymphomatoid Granulomatosis [C20.683.515.761.480.150.600]
- Lymphoma, Follicular [C20.683.515.761.480.350]
- Lymphoma, Large-Cell, Immunoblastic [C20.683.515.761.480.487]
- Lymphoma, Mantle-Cell [C20.683.515.761.480.525]
- Lymphoma, T-Cell [C20.683.515.761.480.750]
- Enteropathy-Associated T-Cell Lymphoma [C20.683.515.761.480.750.199]
- Lymphoma, Large-Cell, Anaplastic [C20.683.515.761.480.750.399]
- Lymphoma, T-Cell, Cutaneous [C20.683.515.761.480.750.800]
- Lymphoma, T-Cell, Peripheral [C20.683.515.761.480.750.825]
- Macrophage Activation Syndrome [C20.683.515.800]
- Marek Disease [C20.683.515.840]
- Multiple Myeloma [C20.683.515.845]
- Plasmacytoma [C20.683.515.880]
- Sezary Syndrome [C20.683.515.920]
- Tumor Lysis Syndrome [C20.683.515.950]
- Paraproteinemias [C20.683.780]
- Purpura, Thrombocytopenic [C20.841]
- Autoimmune Diseases [C20.111]
Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
